Each essential oil is declared by its botanical name rather than grouped under 'Parfum' or 'Fragrance' — the more transparent labelling approach. However, the cumulative fragrance allergen load in this product is significant. Five EU-declared allergens (Linalool, Limonene, Citral, Citronellol, Geraniol) come from four essential oils: Lavender, Geranium, Rosemary, and Coriander. This is an overnight leave-on product, meaning the skin is in contact with these allergens for 8 or more hours during its nightly repair cycle. Fragrance sensitisation is cumulative — repeated exposure over time increases the chance of developing a reaction, even without any immediate irritation at first use.

The oil base genuinely delivers on the emolliency and barrier-repair claim. Rosehip Oil (Rosa Canina) is rich in linoleic acid and beta-carotene. Evening Primrose Oil (Oenothera Biennis) has a high gamma-linolenic acid content with anti-inflammatory properties. Jojoba (Simmondsia Chinensis) is a liquid wax ester that is non-comedogenic and a well-proven carrier. Squalane provides additional barrier support. The skin recovery comes from this oil base, not from the essential oil blend — the fragrance serves an aesthetic purpose only and adds no therapeutic benefit to overnight skin repair.

All allergens are declared as required under EU regulation, and the full INCI is published on the Kiehl's product page. What isn't communicated is the distinction between what actually produces the recovery effect (the plant oil base) and what the essential oil blend contributes (fragrance only). At a price point around ₹6,000, a consumer reading the marketing would reasonably assume the essential oils are doing therapeutic work — they are not.

Kiehl's is owned by L'Oréal, which sells in mainland China where animal testing can be required by regulation. No PETA certification. Standard packaging.